CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 92 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,411,000 | +4.5% | 25,298 | 0.0% | 0.04% | +2.5% |
| Q1 2019 | $2,308,000 | +20.2% | 25,298 | 0.0% | 0.04% | +5.3% |
| Q4 2018 | $1,920,000 | -39.0% | 25,298 | -35.7% | 0.04% | -13.6% |
| Q3 2018 | $3,146,000 | -19.5% | 39,326 | 0.0% | 0.04% | -17.0% |
| Q2 2018 | $3,906,000 | +22.6% | 39,326 | 0.0% | 0.05% | +20.5% |
| Q1 2018 | $3,185,000 | +36.1% | 39,326 | +32.4% | 0.04% | +37.5% |
| Q4 2017 | $2,340,000 | +34.7% | 29,702 | +57.8% | 0.03% | +23.1% |
| Q3 2017 | $1,737,000 | – | 18,827 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Maso Capital Partners Ltd | 143,300 | $11,464,000 | 11.16% |
| Hillhouse Capital Management | 2,751,200 | $220,096,000 | 5.88% |
| York Capital Management Global Advisors, LLC | 1,167,643 | $93,411,000 | 2.95% |
| Kite Lake Capital Management (UK) LLP | 152,836 | $12,227,000 | 2.53% |
| RUDMAN ERROL M | 80,000 | $6,400,000 | 2.39% |
| Dalton Investments, Inc. | 54,551 | $4,364,000 | 2.04% |
| Greenwoods Asset Management Ltd | 245,000 | $19,600,000 | 1.91% |
| Point72 Hong Kong Ltd | 47,296 | $3,784,000 | 1.29% |
| Temasek Holdings (Private) Ltd | 990,000 | $79,200,000 | 0.46% |
| Kassirer Asset Management Corp | 6,000 | $480,000 | 0.32% |